← Leaderboards
Wenli Cai
Iq Medical Imaging, Llc
$1,843,650
Attributed
$3,518,799
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2014–19$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,518,799 · 5
By mechanism
R42$2,902,504 · 2
R41$447,795 · 2
R03$168,500 · 1
Top collaborators
- Yin Wu6 shared
Others in their field
Top investigators on “Validation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,091,456
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$239,311,963
Research focus
ValidationClinical ResearchEvaluationImaging ModalityPerformanceTumor ProgressionComputer SoftwareTumorThree-Dimensional ImagingTechnologyAgreementCostBaseTranslationsIntuitionResearch Clinical TestingImage AnalysisNamesMassachusettsRunningGeneral HospitalsFundingTreatment ResponseInterest
Grant awards (8)
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses$719,403
R42 · FY2019 · CA
MDCT Quantification of hepatic tumor viability for assessment of cancer therapy$716,642
R42 · FY2019 · CA
Electronic cleansing based on effective atomic numbers in dual-energy CT colonography$84,250
R03 · FY2019 · CA · contact PI
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses$740,417
R42 · FY2018 · CA
MDCT Quantification of hepatic tumor viability for assessment of cancer therapy$726,042
R42 · FY2018 · CA
Electronic cleansing based on effective atomic numbers in dual-energy CT colonography$84,250
R03 · FY2018 · CA · contact PI
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses$225,000
R41 · FY2015 · CA
MDCT Quantification of hepatic tumor viability for assessment of cancer therapy$222,795
R41 · FY2014 · CA